[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Age Related Macular Degeneration Drug Market Report 2018

February 2018 | 115 pages | ID: A08A8BEE449EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Age Related Macular Degeneration Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Age Related Macular Degeneration Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Age Related Macular Degeneration Drug market competition by top manufacturers/players, with Age Related Macular Degeneration Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Applied Genetic Technologies Corp
  • Astellas Pharma Inc
  • Benitec Biopharma Ltd
  • Biokine Therapeutics Ltd
  • Crinetics Pharmaceuticals Inc
  • Critical Pharmaceuticals Ltd
  • Daiichi Sankyo Company Ltd
  • Diffusion Pharmaceuticals Inc
  • Dong-A Socio Holdings Co Ltd
  • Eleven Biotherapeutics Inc
  • Elsalys Biotech SAS
  • Lupin Ltd
  • M's Science Corp
  • Mabion SA
  • MacuCLEAR Inc
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Lucentis
  • Eylea
  • Avastin
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Age Related Macular Degeneration Drug Market Report 2017

1 AGE RELATED MACULAR DEGENERATION DRUG OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug by Product Category
  1.2.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Age Related Macular Degeneration Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Lucentis
  1.2.4 Eylea
  1.2.5 Avastin
  1.2.6 Others
1.3 Asia-Pacific Age Related Macular Degeneration Drug Market by Application/End Users
  1.3.1 Asia-Pacific Age Related Macular Degeneration Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Asia-Pacific Age Related Macular Degeneration Drug Market by Region
  1.4.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2012-2022)
  1.5.1 Asia-Pacific Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC AGE RELATED MACULAR DEGENERATION DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Age Related Macular Degeneration Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Age Related Macular Degeneration Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Age Related Macular Degeneration Drug (Volume) by Application
2.4 Asia-Pacific Age Related Macular Degeneration Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Age Related Macular Degeneration Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Market Share by Region (2012-2017)

3 CHINA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  3.1.1 China Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
3.2 China Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
3.3 China Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

4 JAPAN AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  4.1.1 Japan Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
4.2 Japan Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
4.3 Japan Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

5 SOUTH KOREA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  5.1.1 South Korea Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
5.2 South Korea Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
5.3 South Korea Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

6 TAIWAN AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
6.2 Taiwan Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
6.3 Taiwan Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

7 INDIA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  7.1.1 India Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
7.2 India Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
7.3 India Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

9 AUSTRALIA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  9.1.1 Australia Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
9.2 Australia Age Related Macular Degeneration Drug Sales Volume and Market Share by Type
9.3 Australia Age Related Macular Degeneration Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC AGE RELATED MACULAR DEGENERATION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Applied Genetic Technologies Corp
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Astellas Pharma Inc
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Benitec Biopharma Ltd
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Biokine Therapeutics Ltd
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Crinetics Pharmaceuticals Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Critical Pharmaceuticals Ltd
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Daiichi Sankyo Company Ltd
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Diffusion Pharmaceuticals Inc
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Dong-A Socio Holdings Co Ltd
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Eleven Biotherapeutics Inc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Elsalys Biotech SAS
10.12 Lupin Ltd
10.13 M's Science Corp
10.14 Mabion SA
10.15 MacuCLEAR Inc

11 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

11.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Age Related Macular Degeneration Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Age Related Macular Degeneration Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Age Related Macular Degeneration Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Age Related Macular Degeneration Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Age Related Macular Degeneration Drug
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Lucentis Product Picture
Figure Eylea Product Picture
Figure Avastin Product Picture
Figure Others Product Picture
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Age Related Macular Degeneration Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Age Related Macular Degeneration Drug Market Size (Million USD) by Region (2012-2022)
Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Age Related Macular Degeneration Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Age Related Macular Degeneration Drug Revenue Share by Players
Figure 2017 Asia-Pacific Age Related Macular Degeneration Drug Revenue Share by Players
Table Asia-Pacific Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Region (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Region in 2016
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Region (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table China Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure Japan Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure South Korea Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table South Korea Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table Taiwan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure India Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure India Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table India Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure India Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Figure Australia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2016
Table Australia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2016
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Basic Information List
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Basic Information List
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Basic Information List
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Basic Information List
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Basic Information List
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Basic Information List
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Basic Information List
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Basic Information List
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Basic Information List
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Basic Information List
Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Elsalys Biotech SAS Age Related Macular Degeneration Drug Basic Information List
Table Lupin Ltd Age Related Macular Degeneration Drug Basic Information List
Table M's Science Corp Age Related Macular Degeneration Drug Basic Information List
Table Mabion SA Age Related Macular Degeneration Drug Basic Information List
Table MacuCLEAR Inc Age Related Macular Degeneration Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region in 2022
Figure China Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Age Related Macular Degeneration Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories